Esperienze
Specialista in Medicina Interna, perfezionato in Epatologia. Ha conseguito il Dottorato di Ricerca in Scienze Cliniche, Mediche e Sperimentali presso l'Università degli Studi della Campania "L. Vanvitelli"
Esperienze
Riccardo Nevola
epatologo, internista, Ecografista
Patologie trattate
- Epatite C
- Epatite B
- Cirrosi epatica
- Epatocarcinoma
- Calcolosi della colecisti
- Ipertensione portale
- Malattie autoimmuni
- Tumore del fegato
- Colangite biliare primitiva
- Epatite delta
- Colangite sclerosante primitiva
- Epatite cronica da alcol
Competenze linguistiche
- Italiano
- Inglese
Tirocini
- AOU Vanvitelli di Napoli
- Ospedale Anastasia Guerriero di Marcianise (CE)
Pubblicazioni
- Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma (Biology, 2023 Jul)
- Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? (Cancers, 2023 May)
- HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis (Int J Mol Sci, 2023 Apr)
- Predictors of early and late hepatocellular carcinoma recurrence (World J Gastroenterol, 2023 Feb)
- Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies (Biomedicines, 2023 Feb)
- Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination (World J Gastroenterol, 2023 Feb)
- GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives (Int J Mol Sci, 2023 Jan)
- Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy (J Clin Med, 2022 Oct)
- Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies (Biology, 2022 May)
- Telemedicine Improves HCV Elimination among Italian People Who Use Drugs: An Innovative Therapeutic Model to Increase the Adherence to Treatment into Addiction Care Centers Evaluated before and during the COVID-19 Pandemic (Biology, 2022 May)
- Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions (Viruses, 2022 May)
- Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic-Standardized National Screening or One Tailored to Local Epidemiology? (Biology, 2022 Apr)
- Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study (J Viral Hepat, 2022 Jan)
- A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy (Viruses, 2021 Nov)
- Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience (Am J Gastroenterol, 2021 Jun)
- Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes (Nutr Metab Cardiovasc Dis, 2021 Jul)
- Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals (Expert Rev Gastroenterol Hepatol, 2021 Jun)
- Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study (Life, 2020 Dec)
- Unusual liver-related heart injury (JGH Open, 2020 Jun)
- Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study (PLoS One, 2020 Dec)
- Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management (Minerva Med, 2021 Apr)
- Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals (JGH Open, 2020 Mar)
- Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study (Diabetes Obes Metab, 2020 Dec)
- Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics (Cancers, 2020 May)
- HCC in HCV patients and the direct acting antivirals: is there really a link? (Eur Rev Med Pharmacol Sci, 2020 Jan)
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study (Atherosclerosis, 2020 Mar)
- Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study (J Transl Med, 2019 Aug)
- Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience (Dig Dis Sci, 2019 Oct)
- Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? (World J Gastroenterol, 2018 Nov)
- Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress (Infection, 2018 Dec)
- Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis (J Hepatol, 2018 Jul)
- Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients (J Gastroenterol Hepatol, 2018 Jul)
- Chronic Hepatitis C Virus Infection and Depression (Clin Liver Dis, 2017 Aug)
- Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis (World J Gastroenterol, 2017 Feb)
- Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview (World J Gastroenterol, 2015 Feb)
- nsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression (World J Hepatol, 2014 Sep)
Formazione
- Università degli Studi della Campania Luigi Vanvitelli
Specializzazioni
- Medicina Interna
Certificati
Premi e riconoscimenti
- .
Indirizzo
Pazienti senza assicurazione sanitaria
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Tempo medio di risposta:
Visita epatologica • Da 90 €
Ecografia addome superiore • Da 55 €
Visita epatologica + ecografia • Da 125 € +2 Altro
Visita epatologica + ecografia • Da 100 €
Visita epatologica di controllo • Da 65 €
16 recensioni
Punteggio generale
Ordina recensioni per
Ga
Molto cortese, disponibile e puntuale. Ti mette a tuo agio.
C.C.
Soddisfatta per la professionalità, ntualità e competenza
Marina C.
il dott. Nevola e' un professionista
di grande spessore, umano e competente!!!
S.C.
Persona premurosa cortese ,amante del proprio lavoro
dall' altissima professionalità
Qualità difficili da trovare .
Domenico Chinelli
Medico molto attento e scrupoloso, chiaro nelle spiegazioni e nella valutazione della patologia, consigli appropriati e richiesta di esami specifici e approfonditi.
Andrea F.
Visita molto approfondita, mi ha spiegato in modo semplice ed efficiente tutto. Molto gentile e competente.
Alessandro
La visita è stata accurata e minuziosa. Il dottore è stato davvero molto gentile e disponibile. Spiega in modo semplice e professionale.
Sara
Il dottore segue mio marito da qualche mese, bravo e in gamba.. affidatevi a medici competenti quando si tratta di patologie importanti. Lo consiglio
Matteo
Ho effettuato una prima visita epatologica con il Dottor Nevola e devo dire che sono da subito ho riscontrato serietà e professionalità..Dottore molto gentile e preparato.
C.
Dottore Competente e professionale, è stata una visita molto dettagliata, difficile trovare medici così preparati e gentili.
I prezzi di alcune prestazioni possono variare a seconda del singolo caso. Dopo aver effettuato una prenotazione, puoi chiedermi il prezzo di una specifica prestazione inviandomi un messaggio privato. Prenota ora la data più adatta alle tue esigenze.
Tempo medio di risposta: